Literature DB >> 23470207

Prevascularization of a gas-foaming macroporous calcium phosphate cement scaffold via coculture of human umbilical vein endothelial cells and osteoblasts.

WahWah Thein-Han1, Hockin H K Xu.   

Abstract

The lack of a vasculature in tissue-engineered constructs is currently a major challenge in tissue regeneration. There has been no report of prevascularization of macroporous calcium phosphate cement (CPC) via coculture of endothelial cells and osteoblasts. The objectives of this study were to (1) investigate coculture of human umbilical vein endothelial cells (HUVEC) and human osteoblasts (HOB) on macroporous CPC for the first time; and (2) develop a new microvasculature-CPC construct with angiogenic and osteogenic potential. A gas-foaming method was used to create macropores in CPC. HUVEC and HOB were seeded with a ratio of HUVEC:HOB=4:1, at 1.5×10(5) cells/scaffold. The constructs were cultured for up to 42 days. CPC with a porosity of 83% had a flexural strength (mean±SD; n=6) of 2.6±0.2 MPa, and an elastic modulus of 340±30 MPa, approaching the reported values for cancellous bone. Reverse transcription-polymerase chain reaction showed that HUVEC+HOB coculture on CPC had much higher vascular endothelial growth factor (VEGF) and collagen I expressions than monoculture (p<0.05). Osteogenic markers alkaline phosphatase, osteocalcin (OC), and runt-related transcription factor 2 (Runx2) were also highly elevated. Immunostaining of PECAM1 (CD31) showed abundant microcapillary-like structures on CPC in coculture at 42 days, as HUVEC self-assembled into extensive branches and net-like structures. However, no microcapillary was found on CPC in monoculture. In immunohistochemical staining, the neo-vessels were strongly positive for PECAM1, the von Willebrand factor, and collagen I. Scanning electron microscopy revealed microcapillary-like structures mingling with mineral nodules on CPC. Cell-synthesized minerals increased by an order of magnitude from 4 to 42 days. In conclusion, gas-foaming macroporous CPC was fabricated and HUVEC+HOB coculture was performed for prevascularization, yielding microcapillary-like structures on CPC for the first time. The novel macroporous CPC-microvasculature construct is promising for a wide range of orthopedic applications with enhanced angiogenic and osteogenic capabilities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23470207      PMCID: PMC3700173          DOI: 10.1089/ten.TEA.2012.0631

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  62 in total

Review 1.  Biomaterials and scaffolds in reparative medicine.

Authors:  Elliot L Chaikof; Howard Matthew; Joachim Kohn; Antonios G Mikos; Glenn D Prestwich; Christopher M Yip
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

2.  Effect of the particle size on the micro and nanostructural features of a calcium phosphate cement: a kinetic analysis.

Authors:  M P Ginebra; F C M Driessens; J A Planell
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

3.  Design of ceramic-based cements and putties for bone graft substitution.

Authors:  M Bohner
Journal:  Eur Cell Mater       Date:  2010-07-01       Impact factor: 3.942

4.  The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering.

Authors:  Hongzhi Zhou; Hockin H K Xu
Journal:  Biomaterials       Date:  2011-07-14       Impact factor: 12.479

5.  The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats.

Authors:  Esther W H Bodde; Otto C Boerman; Frans G M Russel; Antonios G Mikos; Paul H M Spauwen; John A Jansen
Journal:  J Biomed Mater Res A       Date:  2008-12-01       Impact factor: 4.396

6.  Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF?

Authors:  F Villars; L Bordenave; R Bareille; J Amédée
Journal:  J Cell Biochem       Date:  2000-09-14       Impact factor: 4.429

7.  Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40.

Authors:  Alexander M Simon; Andrea R McWhorter
Journal:  Dev Biol       Date:  2002-11-15       Impact factor: 3.582

8.  Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization.

Authors:  Marina I Santos; Ronald E Unger; Rui A Sousa; Rui L Reis; C James Kirkpatrick
Journal:  Biomaterials       Date:  2009-05-31       Impact factor: 12.479

9.  The tensile properties of alginate hydrogels.

Authors:  Jeanie L Drury; Robert G Dennis; David J Mooney
Journal:  Biomaterials       Date:  2004-07       Impact factor: 12.479

10.  Fast-setting calcium phosphate scaffolds with tailored macropore formation rates for bone regeneration.

Authors:  Hockin H K Xu; Shozo Takagi; Janet B Quinn; Laurence C Chow
Journal:  J Biomed Mater Res A       Date:  2004-03-15       Impact factor: 4.396

View more
  12 in total

1.  The influence of osteopontin-guided collagen intrafibrillar mineralization on pericyte differentiation and vascularization of engineered bone scaffolds.

Authors:  Cristiane M França; Greeshma Thrivikraman; Avathamsa Athirasala; Anthony Tahayeri; Laurie B Gower; Luiz E Bertassoni
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2018-09-29       Impact factor: 3.368

2.  Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell co-culture with human bone marrow mesenchymal stem cells (MSCs), human umbilical cord MSCs, human induced pluripotent stem cell-derived MSCs and human embryonic stem cell-derived MSCs.

Authors:  Wenchuan Chen; Xian Liu; Qianmin Chen; Chongyun Bao; Liang Zhao; Zhimin Zhu; Hockin H K Xu
Journal:  J Tissue Eng Regen Med       Date:  2017-06-13       Impact factor: 3.963

3.  Co-Seeding Human Endothelial Cells with Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on Calcium Phosphate Scaffold Enhances Osteogenesis and Vascularization in Rats.

Authors:  Xian Liu; Wenchuan Chen; Chi Zhang; Wahwah Thein-Han; Kevin Hu; Mark A Reynolds; Chongyun Bao; Ping Wang; Liang Zhao; Hockin H K Xu
Journal:  Tissue Eng Part A       Date:  2017-03-10       Impact factor: 3.845

Review 4.  Stem Cells and Calcium Phosphate Cement Scaffolds for Bone Regeneration.

Authors:  P Wang; L Zhao; W Chen; X Liu; M D Weir; H H K Xu
Journal:  J Dent Res       Date:  2014-05-05       Impact factor: 6.116

Review 5.  Engineering 3D Models of Tumors and Bone to Understand Tumor-Induced Bone Disease and Improve Treatments.

Authors:  Kristin A Kwakwa; Joseph P Vanderburgh; Scott A Guelcher; Julie A Sterling
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

6.  Prevascularization of biofunctional calcium phosphate cement for dental and craniofacial repairs.

Authors:  Wenchuan Chen; WahWah Thein-Han; Michael D Weir; Qianming Chen; Hockin H K Xu
Journal:  Dent Mater       Date:  2014-05       Impact factor: 5.304

Review 7.  Artificial small-diameter blood vessels: materials, fabrication, surface modification, mechanical properties, and bioactive functionalities.

Authors:  Dongfang Wang; Yiyang Xu; Qian Li; Lih-Sheng Turng
Journal:  J Mater Chem B       Date:  2020-03-04       Impact factor: 6.331

Review 8.  Bone physiology as inspiration for tissue regenerative therapies.

Authors:  Diana Lopes; Cláudia Martins-Cruz; Mariana B Oliveira; João F Mano
Journal:  Biomaterials       Date:  2018-09-17       Impact factor: 12.479

Review 9.  Recent advances in bioprinting techniques: approaches, applications and future prospects.

Authors:  Jipeng Li; Mingjiao Chen; Xianqun Fan; Huifang Zhou
Journal:  J Transl Med       Date:  2016-09-20       Impact factor: 5.531

Review 10.  Calcium phosphate cements for bone engineering and their biological properties.

Authors:  Hockin Hk Xu; Ping Wang; Lin Wang; Chongyun Bao; Qianming Chen; Michael D Weir; Laurence C Chow; Liang Zhao; Xuedong Zhou; Mark A Reynolds
Journal:  Bone Res       Date:  2017-12-20       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.